TET2 and myeloproliferative neoplasm: Mutations in TET2 have been found in a range of hematological malignancies, including AML, MDS, myeloproliferative neoplasms (MPN), and chronic myelomonocytic leukemia (CMML) with frequencies of 24%, 19%, 12% and 22%, respectively [23].